# Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects

> **NCT04349761** · PHASE1 · COMPLETED · sponsor: **TNF Pharmaceuticals, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Undefined

## Interventions

- **DRUG:** MyMD1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04349761
- **Lead sponsor:** TNF Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-11
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349761, "Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04349761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*